These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3318539)

  • 21. Marked inhibition of histamine formation in transplantable histamine-producing gastric carcinoid of Mastomys natalensis by (S)-alpha-fluoromethylhistidine and its potent antiulcer effect on tumor-bearing hosts.
    Hosoda S; Saito T; Kumazawa H; Watanabe T; Wada H
    Biochem Pharmacol; 1985 Dec; 34(24):4327-9. PubMed ID: 4074392
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect on mast cell histamine of inhibiting histamine formation in vivo with alpha-fluoromethylhistidine.
    Lagunoff D; Ray A; Rickard A
    Biochem Pharmacol; 1985 Apr; 34(8):1205-9. PubMed ID: 3994743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies.
    Garbarg M; Barbin G; Rodergas E; Schwartz JC
    J Neurochem; 1980 Nov; 35(5):1045-52. PubMed ID: 7452304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.
    Bartholeyns J; Bouclier M
    Cancer Res; 1984 Feb; 44(2):639-45. PubMed ID: 6692368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alpha-fluoromethylhistidine (FMH), an irreversible inhibitor of histidine decarboxylase, on development of brain histamine and catecholamine systems in the neonatal rat.
    Slotkin TA; Slepetis RJ; Weigel SJ; Whitmore WL
    Life Sci; 1983 Jun; 32(25):2897-903. PubMed ID: 6855476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local application of atropine attenuates the upper airway reaction to cold, dry air.
    Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
    Am Rev Respir Dis; 1992 Aug; 146(2):340-6. PubMed ID: 1489122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air.
    Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):761-5. PubMed ID: 1706910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen.
    Majchel AM; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Clin Exp Allergy; 1990 Nov; 20(6):701-5. PubMed ID: 1707333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
    Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen-induced specific and non-specific nasal reactions. Reciprocal relationship and inhibition by topical glucocorticosteroids.
    Andersson M; Andersson P; Pipkorn U
    Acta Otolaryngol; 1989; 107(3-4):270-7. PubMed ID: 2648750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of loratadine on allergen-induced histamine release in the nose.
    Andersson M; Nolte H; Baumgarten C; Pipkorn U
    Allergy; 1991 Oct; 46(7):540-6. PubMed ID: 1724592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective irreversible inhibition of mammalian histidine decarboxylase by alpha-chloromethyl histidine [proceedings].
    Lippert B; Bey P; Dorsselaer VA; Vevert JP; Danzin C; Ribereau-Gayon G; Jung MJ
    Agents Actions; 1979 Apr; 9(1):38-9. PubMed ID: 463697
    [No Abstract]   [Full Text] [Related]  

  • 35. Nasal challenge studies with bradykinin: influence upon mediator generation.
    Brunnée T; Nigam S; Kunkel G; Baumgarten CR
    Clin Exp Allergy; 1991 Jul; 21(4):425-31. PubMed ID: 1913265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro inhibition of human histidine decarboxylase by (S)-alpha-fluoromethylhistidine.
    Tung AS; Blake JT; Roman IJ; Vlasses PH; Ferguson RK; Zweerink HJ
    Biochem Pharmacol; 1985 Oct; 34(19):3509-15. PubMed ID: 4052095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergen-induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction.
    Andersson M; von Kogerer B; Andersson P; Pipkorn U
    Allergy; 1987 Nov; 42(8):631-7. PubMed ID: 3322084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines.
    Slotkin TA; Bartolome J; Whitmore WL
    Life Sci; 1983 Nov; 33(21):2137-45. PubMed ID: 6645794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
    Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
    Iliopoulos O; Proud D; Adkinson NF; Creticos PS; Norman PS; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1991 Apr; 87(4):855-66. PubMed ID: 2013680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.